Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNO for TRAGI prevention in ELGAN neonates
NCT02851472Phase 2Unknown
- Sponsor
- New York Medical College
- Start
- Feb 2019
- Primary completion
- Feb 2021
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in necrotizing enterocolitis (NEC), sponsored by New York Medical College. Status: unknown.
02
Drugs
nitric oxide
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT02851472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851472.